Patent · US Active

Compounds

US7709471B2 · kind B2 · utility

3Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 5, 2007
Grant dateMay 4, 2010
Priority date—
Expiry dateApr 24, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

There is provided a compound of formula (I):processes for the manufacture thereof, pharmaceutical compositions thereof and uses in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.